CME Group Inc. is a leading derivatives marketplace operating major exchanges like CME, CBOT, NYMEX, and COMEX. It offers trading in various assets, with a market cap of $99.99 billion. The stock has gained 23.4% in the past year but declined 2.4% in the last three months.

In Q3 of fiscal 2025, CME reported a 3% YOY revenue drop to $1.54 billion, meeting estimates. Its second-highest third-quarter ADV and flat YOY EPS at $2.68 impressed amid market uncertainty. October saw record ADV at 26.3 million contracts, with cryptocurrency ADV soaring 226%.

Analysts project CME’s EPS to grow 8.5% YOY to $11.13 in fiscal 2025 and 3.9% annually to $11.56 in 2026. The stock is rated a “Moderate Buy,” with analysts bullish on its future growth potential. Deutsche Bank upgraded the stock to “Buy” with a target price of $300.

CME’s mean price target of $286.88 indicates a 2.9% upside, with a street-high target of $322 suggesting a 15.5% potential upside. The stock’s performance has analysts optimistic about its future growth, especially in prediction markets.

Read more at Yahoo Finance: Are Wall Street Analysts Predicting CME Group Stock Will Climb or Sink?